WMT
56
-3
THC
61
-4
MCD
50
-4
XOM
42
-2
CMA
59
3
AEE
53
2
PHM
57
2
PSA
48
2
HSY
29
-2
MMM
30
-3
GILD
56
-2
CINF
47
12
PBI
38
2
PYPL
41
-8
ES
53
2
CI
52
3
KR
38
-2
VNO
63
-2
SE
52
-2
MU
35
-8
WMT
56
-3
THC
61
-4
MCD
50
-4
XOM
42
-2
CMA
59
3
AEE
53
2
PHM
57
2
PSA
48
2
HSY
29
-2
MMM
30
-3
GILD
56
-2
CINF
47
12
PBI
38
2
PYPL
41
-8
ES
53
2
CI
52
3
KR
38
-2
VNO
63
-2
SE
52
-2
MU
35
-8
Financhill
Back

Stoke Therapeutics Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
27

STOK
Stoke Therapeutics

Last Price:
12.40
Seasonality Move:
11.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Investing Today: The Best Way To Grow A Small Account

In his free guide, expert Joe Duffy reveals... click here to read on...

Stoke Therapeutics Price Quote

$12.40
-0.11 (-0.88%)
(Updated: October 31, 2024 at 6:55 PM ET)

Stoke Therapeutics Key Stats

Sell
27
Stoke Therapeutics (STOK) is a Sell
Day range:
$12.33 - $12.76
52-week range:
$3.46 - $17.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
39.05
P/B ratio:
2.69%
Volume:
128.4K
Avg. volume:
542.5K
1-year change:
250.42%
Market cap:
$651.8M
Revenue:
$8.8M
EPS:
$-2.18

How Much Does Stoke Therapeutics Make?

Is Stoke Therapeutics Growing As A Company?

Data Unavailable

Stoke Therapeutics Stock Price Performance

What Is Stoke Therapeutics 52-Week High & Low?

Stoke Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Stoke Therapeutics?

Is Stoke Therapeutics Cash Flow Positive?

  • What Is STOK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$80M
  • What Is Stoke Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $130.3M
  • What Is Stoke Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$48.9M

Stoke Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    STOK return on invested capital is -57.17%
  • What Is Stoke Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -41.83%
  • What Is STOK Return On Equity?
    ROE is a measure of profitability and is -57.17%

Stoke Therapeutics Earnings Date & Stock Price

Stoke Therapeutics Competitors

Stoke Therapeutics Dividend Yield

Stoke Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.58%
Revenue: 0% 41.57%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.14
Upside from Last Price: 77%

Major Shareholders

  • How many STOK shares are owned by institutional investors?
    86M STOK shares are owned by institutional investors
  • How many STOK shares are owned by insiders?
    510.6K STOK shares are owned by insiders